Open AccessEasy approach to detect cell immunity to COVID vaccines in common variable immunodeficiency patients
Author(s) -
Yvelise Barrios,
Cristina Álava-Cruz,
Andrés Franco,
Ricardo Cuesta-Martin,
Carmen Cámara,
Víctor Matheu
Publication year - 2022
Publication title -
allergologia et immunopathologia
Language(s) - English
Resource type - Journals
eISSN - 1578-1267
pISSN - 0301-0546
DOI - 10.15586/aei.v50i3.583
Subject(s) - common variable immunodeficiency , medicine , ex vivo , immunology , immune system , antibody , vaccination , in vivo , immunity , cellular immunity , immunodeficiency , immunopathology , biology , microbiology and biotechnology
Patients with primary antibody deficiencies, such as Common Variable Immunodeficiency (CVID), have some problems to assess immune response after coronavirus disease (COVID) vaccination. Cutaneous delayed-type hypersensitivity (DTH) has the potential to be used as a useful, simple, and cheaper tool to assess T-cell (T lymphocyte) function.